CAH — Cardinal Health Income Statement
0.000.00%
- $33.23bn
- $37.10bn
- $226.83bn
- 81
- 70
- 100
- 97
Annual income statement for Cardinal Health, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | R2022 June 30th | R2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 152,922 | 162,467 | 181,326 | 204,979 | 226,827 |
Cost of Revenue | |||||
Gross Profit | 6,868 | 6,778 | 6,484 | 6,874 | 7,414 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 157,036 | 162,009 | 181,943 | 204,227 | 225,584 |
Operating Profit | -4,114 | 458 | -617 | 752 | 1,243 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3,772 | 323 | -784 | 663 | 1,201 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3,693 | 612 | -937 | 331 | 853 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -3,696 | 611 | -938 | 330 | 852 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3,696 | 611 | -938 | 330 | 852 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.86 | 5.02 | 4.29 | 5.08 | 6.75 |
Dividends per Share |